Valosin-containing protein-related myopathy and Meige syndrome: Just a coincidence or not?
Corresponding Author
Constantinos Papadopoulos MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Correspondence
Constantinos Papadopoulos; 1st Department of Neurology, University of Athens, Medical School, Eginition Hospital, 72, Vas. Sophias Avenue, 11528, Athens, Greece.
Email: [email protected]
Search for more papers by this authorEdoardo Malfatti MD, PhD
Neurology Department, Raymond-Poincaré teaching hospital, centre de référence des maladies neuromusculaires Nord/Est/Ile-de-France, AP-HP, Garches, France
Search for more papers by this authorEvangelos Anagnostou MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Search for more papers by this authorMarco Savarese PhD
The Folkhälsan Institute of Genetics, Helsinki, Finland
Department of Medical Genetics, Medicum, University of Helsinki, Finland
Search for more papers by this authorBjarne Udd MD, PhD
The Folkhälsan Institute of Genetics, Helsinki, Finland
Department of Medical Genetics, Medicum, University of Helsinki, Finland
Tampere Neuromuscular Center, University and University Hospital of Tampere, Finland
Search for more papers by this authorGeorge Konstantinos Papadimas MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Search for more papers by this authorCorresponding Author
Constantinos Papadopoulos MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Correspondence
Constantinos Papadopoulos; 1st Department of Neurology, University of Athens, Medical School, Eginition Hospital, 72, Vas. Sophias Avenue, 11528, Athens, Greece.
Email: [email protected]
Search for more papers by this authorEdoardo Malfatti MD, PhD
Neurology Department, Raymond-Poincaré teaching hospital, centre de référence des maladies neuromusculaires Nord/Est/Ile-de-France, AP-HP, Garches, France
Search for more papers by this authorEvangelos Anagnostou MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Search for more papers by this authorMarco Savarese PhD
The Folkhälsan Institute of Genetics, Helsinki, Finland
Department of Medical Genetics, Medicum, University of Helsinki, Finland
Search for more papers by this authorBjarne Udd MD, PhD
The Folkhälsan Institute of Genetics, Helsinki, Finland
Department of Medical Genetics, Medicum, University of Helsinki, Finland
Tampere Neuromuscular Center, University and University Hospital of Tampere, Finland
Search for more papers by this authorGeorge Konstantinos Papadimas MD, PhD
First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Search for more papers by this authorCONFLICT OF INTEREST
Evangelos Anagnostou has received consultancy and travel grants from Allergan, Greece. The rest of the authors have no conflict of interest to disclose.
REFERENCES
- 1Evangelista T, Weihl CC, Kimonis V, Lochmüller H. VCP related diseases Consortium. 215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands. Neuromuscul Disord. 2016; 26: 535-547.
- 2Tolosa ES. Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases. Arch Neurol. 1981; 38: 147-151.
- 3Papadimas GK, Paraskevas GP, Zambelis T, et al. The multifaceted clinical presentation of VCP-proteinopathy in a Greek family. Acta Myol. 2017; 36: 203-206.
- 4Mizuno Y, Hori S, Kakizuka A, Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett. 2003; 343: 77-80.
- 5Mori F, Tanji K, Toyoshima Y, et al. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Neuropathology. 2013; 33: 637-644.
- 6Forman MS, Mackenzie IR, Cairns NJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol. 2006; 65: 571-581.
- 7Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007; 114: 221-229.
- 8Mark MH, Sage JI, Dickson DW, et al. Meige syndrome in the spectrum of Lewy body disease. Neurology. 1994; 44: 1432-1436.
- 9Micheli F, Scorticati MC, Folgar S, Gatto E. Development of Parkinson's disease in patients with blepharospasm. Mov Disord. 2004; 19: 1069-1072.
- 10Béreau M, Tatu L. Brueghel syndrome or Meige syndrome? Two sides of a same disease. Front Neurol Neurosci. 2018; 41: 98-103.
Citing Literature
